Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial.

[1]  P. Armstrong,et al.  Randomized Double-Blind Trial of Darbepoetin Alfa in Patients With Symptomatic Heart Failure and Anemia , 2008, Circulation.

[2]  E. Wolfel,et al.  Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). , 2007, Journal of cardiac failure.

[3]  Gabriel E. Soto,et al.  Identifying Heart Failure Patients at High Risk for Near-Term Cardiovascular Events With Serial Health Status Assessments , 2007, Circulation.

[4]  A. Ranchor,et al.  The effect of beta‐blocker therapy on quality of life in heart failure patients: a systematic review and meta‐analysis , 2007, Pharmacoepidemiology and drug safety.

[5]  G. Lamas,et al.  Characterization of health‐related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM , 2007, European journal of heart failure.

[6]  J. Spertus,et al.  Impact of obesity on the health status of heart failure patients. , 2006, Journal of cardiac failure.

[7]  J. Cohn,et al.  Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. , 2006, Journal of cardiac failure.

[8]  H. Krumholz,et al.  Health status identifies heart failure outpatients at risk for hospitalization or death. , 2006, Journal of the American College of Cardiology.

[9]  H. Krumholz,et al.  The relationship between B-type natriuretic peptide and health status in patients with heart failure. , 2005, Journal of cardiac failure.

[10]  F. Rodríguez‐Artalejo,et al.  Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. , 2005, Archives of internal medicine.

[11]  M. Hőgye.  [Management of chronic heart failure]. , 2005, Orvosi hetilap.

[12]  L. Tavazzi,et al.  Effect of valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan Heart Failure Trial. , 2005, Journal of cardiac failure.

[13]  I. S. Virk,et al.  Combination of Isosorbide Dinitrate and Hydralazine in Blacks With Heart Failure , 2005 .

[14]  J. Spertus,et al.  Predictors of the onset of depressive symptoms in patients with heart failure. , 2004, Journal of the American College of Cardiology.

[15]  H. Krumholz,et al.  Age, functional capacity, and health-related quality of life in patients with heart failure. , 2004, Journal of cardiac failure.

[16]  Gabriel E. Soto,et al.  Prognostic Value of Health Status in Patients With Heart Failure After Acute Myocardial Infarction , 2004, Circulation.

[17]  D. Burkhoff,et al.  Development and validation of a patient questionnaire to determine New York Heart Association classification. , 2004, Journal of cardiac failure.

[18]  Harlan M Krumholz,et al.  Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. , 2003, Journal of the American College of Cardiology.

[19]  J. Cohn,et al.  Effect of Valsartan on hospitalization: results from Val-HeFT. , 2003, Journal of cardiac failure.

[20]  S. Czajkowski,et al.  The effect of digoxin on the quality of life in patients with heart failure. , 2003, Journal of cardiac failure.

[21]  Anne L. Taylor,et al.  African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology. , 2002, Journal of cardiac failure.

[22]  F. Alla,et al.  Self‐rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study , 2002, European journal of heart failure.

[23]  R. Berger,et al.  Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living with Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. , 2002, European heart journal.

[24]  A. Dilenarda,et al.  [Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[25]  John Wikstrand,et al.  Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) , 2000 .

[26]  L. Goldman,et al.  Gender differences in 1-year survival and quality of life among patients admitted with congestive heart failure. , 1998, Medical care.

[27]  S. Yusuf,et al.  Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. , 1996, The American journal of cardiology.

[28]  T. Rector,et al.  Use of the Living With Heart Failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. , 1995, Journal of cardiac failure.

[29]  J. Cohn,et al.  Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. , 1993, Circulation.

[30]  R. Niaura,et al.  Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. , 1993, The American journal of cardiology.

[31]  J. Cohn,et al.  Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. , 1993, The American journal of cardiology.

[32]  S. Silver,et al.  Heart Failure , 1937, The New England journal of medicine.

[33]  M. Cheitlin.  Early and Sustained Benefit on Event-Free Survival and Heart Failure Hospitalization From Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine: Consistency Across Subgroups in the African-American Heart Failure Trial , 2008 .

[34]  N. Santanello,et al.  Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: The losartan heart failure ELITE quality of life substudy , 2004, Quality of Life Research.

[35]  T. Rector.  Patients' self-assessment of their congestive heart failure : Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire , 1987 .